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It is estimated that in Italy there are about three million 
people affected by chronic heart failure. Cardiology is the 
health care field currently getting the largest benefits from 
telemedicine. Transmission, using wireless devices,  
makes possible to achieve virtual hospitalization: it is 
possible to anticipate the time of discharging and the 
patient can be remotely controlled by the central station in 
the ICU of the department of Medicine. Teleconsulting 
(i.e. a distance consulting between physicians) is applied 
in telecardiology, it allows the realization of a consulting 
between cardiology departments and remote services in 
the same hospital or among far-away hospitals. 
In this paper some of the most significant cardiac 
telemonitoring projects in Italy are described. Also 
reported, the projects involving the applications of 
implantable cardiac devices which can be controlled 
remotely.  
In conclusion, we sketch out the future prospects of 
telecardiology research and its applications in Italy. 
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Wireless health care is a new health care delivery 
paradigm enabled by technologies and services (better 
described as solutions) whereby patients can have nearly 
continuous access to health care information, expert 
advice, or therapeutic interventions enabled by ubiquitous 
telecommunication networks. Basic functions for 
pervasive health care with respect to home care include 
emergency detection and alarm, disease management, as 
well as health status feedback and advice. The digital 
Agenda for Europe 2020 (a strategy for fast, sustainable 
and inclusive growth) includes, as objective, the  
deployment  of e-health technologies for sustainable 
health care, information and communication technologies 
(ICT)-based support for dignified and independent living, 
including remote places. There are about three million 
people affected by chronic heart failure (5% of the 
population) in Italy. Slightly less than 1/3 of them hold a 
confirmed diagnosis. 
This work sketchs out the current status of cardiac care in 
Italy and highlights how telecardiology can support 
general practitioners in the diagnosis and management of 
acute and chronic cardiac disease, as well as provide the 
potential for screening opportunities in particular for risk 
patients. It is also presented the achievement of recent 
trials of a telecardiology service in our country. 
Patients affected by heart failure (HF) cannot be properly 
and adequately controlled, despite the increasing number 
of ambulatories, especially because of the long waiting 
lists for cardiology visits both in hospitals and at local 
health units.  
The hospital emergency room, then, is often used as a 
"shortcut" for the assistance, and, for legal problems (the 
so-called "defensive medicine") it tends to be used also in 
non-critical situations, causing a waste of economic 
resources. 
Heart Failure accounts for 1 to 2% of total health expense 
in Italy. The main factors causing such costs are: 
hospitalizations, representing the largest component 
(about 70%), medications, outpatient specialist visits and 
mechanical cardiac support devices. 
Cardiology is the field of health care currently getting the 
largest benefits from telemedicine. 
Telecardiology makes possible to achieve a virtual 
hospitalization: it is possible to anticipate the time of 
discharging and the patient can be remotely controlled by 
realizing cardiac telecare at home. 
Teleconsulting (i.e. a distance consulting between 
physicians) is widely applied in telecardiology, allowing 
the realization of a consulting between cardiology 
departments and remote services in the same hospital or 
other hospitals. 
This approach is particularly useful and used mainly by 
private medical care that can’t benefit of a specialist 
cardiology service available 24/7. It is also used in tourist 
resorts medical center or in remote communities, nursing 
homes or rest homes. 
The main applications of remote monitoring are: 
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1) Cardiovascular monitoring systems. These systems 
require the presence of medical practitioners or nurse 
specialists in the place where they are being provided. 
2)  Respiratory monitoring systems. The main parameters 
are: peak flow of breath and volume per second of 
forced respiration that can be transmitted by means of a 
flowmeter to a unit center, via telephone. 
3)  Blood glucose monitoring systems. There is a 
significant set of information for planning and 
conducting a monitoring organization: insulin doses to 
be administered, composition of meals, general 
metabolic status and lifestyle. 
An important application of telemedicine is in the field of 
cardiovascular emergencies. Actuallytelecardiology has 
definitely become part of the integrated management 
system  of patients with acute coronary syndrome, as 
prescribed by all major national and international 
guidelines.  
The timing required for the treatment of myocardial 
infarction with ST-segment elevation makes necessary to 
implement procedures that ensure integrated collaborative 
care spread evenly throughout the region. 
Although telecardiology is still in its infancy, data suggest 
that patients with congestive heart failure draw the largest 





Many Italian regions have well organized systems for the 
diagnosis and management of the acute coronary 
syndromes, such as Apulia with "RETE IMA" project, 
Lombardy with "PROVA e TRASPORTA" and "GEST 
IMA" project, Latium with “INFARTO.NET” project. 
Lombardy is the only Italian region that has managed to 
integrate telemedicine with the healthcare national 
system.  “Telmed Platform” is one of the most relevant 
achievements. It is a health care platform supporting 
telemedicine services realized by HTN [1]. HTN (Health 
Telematic Network) is a company working in Brescia 
(Northern Italy) since the 1990s, able to implement 
efficient and effective telemedicine services. By means of 
Telmed Platform it is possible: 
- to enable health care operators on the territory to access 
health information, 
- to integrate hospital information systems for data 
exchanging, 
- to acquire data from devices and monitoring systems, 
- to allow interoperability with local-based structures for 
administrative and reporting tasks, 
- to manage interaction with patients, 
- to perform teleconference. 
Terminals are set up in universities and public hospitals, 
functionally linked with the Service Center, and 
configured in order to share application programs of the 
central station with onsite and online licences. The service 
centre provides technological and organizing support, 
while healthcare activity is carried out by the hospital’s 
cardiologists and nurses. 
This platform is accessible by any web browser and can 
be customized according to local needs. It can support all 
different phases of patient management, i.e.: 
- acquisition of vital parameters, 
- contact with a call center operator, 
- referring to the specialist physician with automatic 
access to clinical data, 
- archiving of information and biosignals, 
- report generation, 
- communication to external systems (e.g. local health 
systems, hospital information systems) of relevant 
information. 
HTN is also able to offer wireless solutions in modular 
systems composed by three elements: 
1. “HTN Bee-P Mobile”, an application installed on a 
mobile phone transmitting the patient’s vital parameters to 
the telemedicine service centre. 
2. “Bee-P Services” acquiring such data by mobile 
gateway. 3. “Bee-P Web” for optimal data visualization. It 
is a web integrated system inside the Service Center 
platform. 
The “Lancisi” hospital in Ancona has been carrying on a 
project on HF and telecardiology aimed to the palliative 
treatment of patients not eligible for transplantation [2]. 
The project is focused on remote monitoring and follow-
up of patients at home. 
Four different cardiology units are able to monitor the 
patients 24/7. A teleconsulting service offering a second 
opinion is also available. Patients with an implantable 
cardioverter defibrillator or a pacemaker are remotely 
monitored also by an arithmologist. 
Data collected are also used for statistical and scientific 
purposes. 
This approach guarantees a high appropriateness in the 
supply of medical care. Obviously, the online 
teleconsulting shortens waiting time and increases the 
percentage of patients treated with beta-blockers and 
angiotensin-converting enzyme (ACE) inhibitors 
according to guidelines. 
Another supported application is home care featuring 
inotropic therapy in selected patients in need of palliative 
care. 
The “San Giovanni-Addolorata” hospital in Rome, is also 
offering a telemedicine service providing patients with a 
briefcase, containing biomedical equipments. In such a 
way, a sort of “virtual hospital bed” is realized at patients’ 
home [3] and also at patient’s prison. 
The case is equipped with a blood pressure measurement 
system (BPMS), a 12-lead electrocardiograph, a pulse 
oximeter and a blood glucose metre connected to a 
palmtop computer. The use of a palmtop computer allows 
patients to be trained step by step in self monitoring.  
Such computer acts not only as a data collector to be sent 
to the server, but also provides a series of information to 
patients among which their current treatment or the 





3. Implanted devices 
 
In the last five years many Italian biomedical companies 
have focused their efforts in research and development in 
order to realize implantable remotely controlled cardiac 
devices. These new tools, allowing remote monitoring of 
implanted patients, are referred as Remote Patient 
Management (RPM). 
In 2006, the Heart Rhythm Society recommended to 
develop devices for cardiac rhythm management using 
wireless technologies and remote monitoring in order to: 
• immediately identify abnormal behaviour of the device; 
• reduce the incomplete reports of the device 
malfunctioning, checking more often and more 
accurately the state of its functions [2]. 
RPM has been shown to have positive effects on clinical 
outcomes and economic management of patients with HF. 
An analysis, conducted by the New England Healthcare 
Institute, estimated that the probability of re-
hospitalization in patients followed with RPM, are down 
to 32% compared to patients followed within normal 
standards [4]. 
In the prevention of re-hospitalization also weight 
monitoring has proved useful. Some researchers  
demonstrated the existence of a statistically significant 
correlation between weight gain and hospitalization due to 
cardiovascular failure (p <0.001) [4][5]. 
The Medtronic CareLink
®
 Network is the leading 
Internet-based system to help physicians and patients to 
manage in better ways chronic cardiovascular disease 
treated by implantable device therapy, such as pacemakers 
and implantable cardioverter-defibrillators (ICDs). 
ICDs are intended to provide ventricular antitachycardia 
pacing and ventricular defibrillation for automated 
treatment of life threatening ventricular arrhythmias. ICDs 
with atrial therapies are also intended to provide atrial 
antitachycardia pacing and atrial defibrillation treatment 
in patients who have, or are at risk of developing, atrial 
tachyarrhythmias. CareLink
®
 Network consists of three 
components: the Carelink
®





 Server. Using CareLink
®
 
Connecting implanted cardiac device data to the 
electronic health record (EHR) and into a personal health 
record (PHR) via a single, easily-managed interface, can 
help healthcare practices maximize efficiency in 
workflow, potentially and significant time and money 
saving. 
For non-wireless telemetry devices, the data transmission 
can only be achieved with the participation of the patient 
who must perform a sequence of simple steps to complete 
the process of data transmitting. Such transmission is 
called "manual transmission". 
Wireless telemetry devices, can perform a “manual 
transmission” or "automatic transmission" that may not 
require any action by the patient. 
The “automatic transmission” can be put up for periodic 
check in specific situations and for programmable DCI 
alarm. Two different kind of automatic transmission exist: 
scheduled and triggered by an alarm event. This second 
type is referred as Transmission CareAlert. 
CareLink
®
 Network was activated in the United States in 
August 2002, while in Italy was introduced for the first 
time in December 2006 in a limited number of centers, 
through a pilot project, which involved a small number of 
patients with biventricular ICD [5][6]. The project's aim 
was to test the feasibility of remote monitoring via 
Carelink
®
 Network and evaluate the usability of the 
Carelink
®
 Monitor by the patient, as well as the 
satisfaction and acceptance of the CareLink
®
 Network 
system both by the patient and the medical staff. To 
evaluate the follow-up remotely service system some 
hospitals were involved: the Department of Management 
of “Politecnico” in Milan, the “San Raffaele” hospital 
IRCSS in Milan, the “Niguarda Ca 'Granda” hospital 
(Milan), the “San Carlo Borromeo” in Milan, the 
“Policlinico San Matteo” in Pavia and the “San Filippo 
Neri” hospital in Rome. 
In Italy, CareLink
®
 Network has been adopted by about 
150 hospital-structures with more than 7,000 patients 
followed in remote mode. Each month there are about 350 
new patients.  
LATITUDE
®
 system produced by Boston Scientific 
S.p.A. from 2009 is available in Europe and it is currently 
used in Italy. LATITUDE
®
 Patient Management system 
allows to monitor in remote mode patients assisted by 
ICD or Cardiac Resynchronization Therapy-Defibrillator 
(CRT-D). CRT-Ds are recommended to patients with 
moderate up to severe HF (NYHA III/IV) who remain 
symptomatic despite stable, optimal HF drug therapy, and 
still have ventricular dysfunction (EF  35%) and QRS 
duration  120 ms. LATITUDE
®
 incorporates a scale and 
a blood pressure monitor, both wireless and therefore can 
meet the Class 1 ESC recommendations for HF [7]. Daily 
made measurements using balance and blood pressure are 
recorded and sent to the database of the patient. These 
data are recorded into the daily report regarding the 
patient health. The progression of HF involves drastic 




 collects data regarding HF from various 
sources (i.e. external sensors for the assessment of the 
weight and pressure) that helps to prevent the onset or the 
progression of HF to determine the moment where action 
is needed. 
Diagnostic tools from implantable devices provide 
information about: 
• Level of activity, accurately monitoring the percentage 
of patient's daily activities, useful prognostic indicator 
in patients undergoing CRT [8]. 
• Heart Rate Variability (HRV), with measurement of 
heart rate average, minimum and maximum on a daily 
basis. These parameters are used to identify changes 
that may have a significant impact on the health of 
patients. An increase in the average heart rate (HR) is 
associated with poor outcome in patients with HF [9]. 
• SDANN -Standard Deviation of the Averages of NN 
(Normal Sinus to Normal Sinus) Intervals-, to better 
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monitor the heart in patients with HF. Patients with 
lower SDANN indexes are at increased risk of cardiac 
events, hospitalization and mortality [10][11]. 
• HRV footprint, to provide a clear visual assessment of 
HRV in the long term. HRV footprint proved to be a 
significant prognostic indicator of mortality in 
correlation with the SDANN [12]. 
Taken individually, the values of these parameters are not 
the same as when evaluated together in the prevention of 
HF, reducing costs and time of hospitalization and 
improving quality of life for patients. 
The LATITUDE system allows physicians to schedule 
remote check-ups of implantable cardiac devices to 
monitor specific device information and patient heart 
health status. It can also detect clinical events between 
scheduled follow-up visits and send relevant data directly 
to physicians. This regular in-home monitoring offers 
convenience and peace of mind for patients.  
 
 
4. Future prospects 
 
The future of home telemonitoring will consist in an  
easier approach through the use of wereable units 
allowing multiparameter telemonitoring. 
In the National Research Council laboratories, researchers 
are studying the realization of wearable devices equipped 
with sensors and a microprocessor on which can be 
implemented mathematical models able to simulate/to 
reproduce a series of physiological and pathological 
conditions for a certain set of human physiological organs 
[13][14]. 
Numerical models that could be implemented on the 
microprocessor are: 
 Numerical models of the cardiovascular system.  
 Numerical models of the respiratory system. 
 Numerical models of liver. 
 Numerical model of kidney. 
 Metabolism of bilirubin.  
 Metabolism of glucose. 
 Glucose-insulin control system.  
 Models to study the drug effects on different 
circulatory districts [15]. 
Some numerical models can be used to evaluate the drugs 
effects in different pathological conditions. Other models 
(developed at Institute of Clinical Physiology CNR) as the 
numerical models of the cardiovascular system allow to 
analyze the interaction between the heart and circulatory 
system and to study the pathophysiological conditions of a 
patient. These models, created as research tools have 
evolved to be used in clinical and educational 
environment (“Sapienza” University, Department of 
Cardiovascular, Respiratory, Nephrological and Geriatic 
Sciences, Rome). In a clinical setting they are used to 
reproduce the pathological condition of a patient from 
easily non-invasively measurable parameters. The 
realization of personalized modular numerical models 
allows: 
• to implement accurately the districts affected by 
cardiovascular disease afflicting the patient under 
observation, 
• to use easily numerical implementation to simulate 
"non-pathological" districts. 
It follows that the parameters measured on a patient may 
vary according to the type of pathology. The measured 
parameters can be used to estimate, through the use of 
numerical models, parameters of clinical interest that are 
not easily and directly measurable. 
A possible application of the use of numerical models of 
the cardiovascular system is that can be achieved for 
patients affected by chronic left ventricular (LV) failure 
due to idiopathic or ischaemic dilated cardiomyopathy 
associated with electromechanical dyssynchrony 
[14][16][17]. This pathology causes irregular muscle 
contractions in the heart resulting in inefficient pumping 
of blood. Cardiac Resynchronization Therapy (CRT) 
improves the coordination of the contractions using 
technology similar to that used in pacemakers and 
implantable cadioverter devices. 
Regular (daily or even continuous) transmittal of data 
regarding heart rate, blood pressure, ECG, weight, body 
temperature, oxygen saturation, or transthoracic 
impedance (for control of fluid overload) can provide a 
basis for disease management decisions of patients 
affected by described pathology. 
All these data together with data regarding pacemakers 
temporization could be measured using integrated sensors 
into device (T-shirt of hypoallergenic material, band, belt 
or otherwise) worn by patient. The same support could be 
equipped with a microprocessor in which a simple 
numerical simulator of the cardiovascular system could be 
implemented. The simulator could estimate some 
haemodynamic parameters (not directly measurable) from 
measurements performed on the patient. In addition, the 
implemented simulator could estimate, using the 
measured data, the best pacemaker temporization 
[16][17]. The measured and predicted data may be sent to 
a Medical Center Unit (MCU) where trained physicians 
could use complex simulator of the cardiovascular system 
to identify the best therapy for patients from the 
parameters measured and simulated [18][21]. This 
approach can produce a significant reduction in the 
median time for clinical decision for cardiac 
resynchronization therapy-defibrillator and implantable 






Telematics application must ensure the electronic medical 
service quality. The task of measuring the quality 
according to certain technical parameters relates to the 
validity of the transmission of signals over telephone or 
via satellite. 
It must be also considered that the chain allowing the 
connection between two computers is a complex system 
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consisting of connectors, cables, interfaces, routers, 
bridges, radio, data acquisition systems data, software, 
telecommunications and other components. Therefore, to 
ensure the quality of the overall system, it is necessary 
that each component of the system is able to ensure the 
desired level of performance: just one link in the chain 
could be sufficient to degrade the entire system. 
Moreover, it is necessary to adopt standards to enable 
interoperability of heterogeneous systems [22]. 
Telemedicine applications, in general, and telecardiology 
in particular, have their own specific clinical application 
field, which, of course, is limited not only to technological 
issues concerning data transmission. Other parameters 
must be taken into account and can be formalized [23]. 
The International Standards Organization (ISO) has 
developed a grid of six key factors (split into different 
characteristics) which a telemedicine/telecardiology 
service must provide [24]: 
a. Trustworthiness (Maturity, Error tolerance, 
Recoverability, Availability, Degradability). 
b. Efficiency (Operation time, Operation of the resource). 
c. Portability (Adaptability, Instability, Compliance, 
Substitutability). 
d. Features (Appropriateness, Accuracy, Interoperability, 
Compliance,  Security, Traceability). 
e. Employability (Intelligibility, Learnability, Operability, 
Clarity, Flexibility, Attraction, Clarity, Utilities, Ease 
of use). 
f. Maintainability (Analyzability, Variability, Stability, 
Testability, Feasibility, Re-usable). 
It is now clear that telecardiology, enabling a better 
interaction between hospital and territory by means of 
teleconsulting, telemonitoring, telecare and remote access 
to clinical information, improves the quality of the whole 
health system. However, it cannot and should not replace 
the essential home care services, but it should be 
integrated properly and profitably with them. 
The evaluation of the operational scenario of 
telecardiology must be made by studying and identifying 
the parameters and technology models which are most 
appropriate to the various clinical situations and therefore 
more useful for medical and cardiological intervention. 
Patients with advanced chronic HF and/or abnormal heart 
rhythms, also monitored with implanted devices, represent 
the most appropriate categories to include in programs of 
continuous cardiac telecare. 
Remote monitoring of devices allows clinicians to quickly 
and thoroughly review the status of a patient’s heart 
condition and any changes occurred since the last in-
person appointment or remote transmission.  
The implementation of such integrated system between 
general medicine and cardiology medicine can represent a 
relevant way of assessing cardiac patients over time and 
avoid inappropriate hospital admissions. 
Finally, the general practitioner and medical personnel, in 
any way involved in the system, may see their level of 
specialist education increased, whereas patients and their 
families can learn to collaborate in the management of 
their disease by having the opportunity of understanding 
the clinical significance of different symptoms and of 
executing, even if under medical/nursing control, medical 
acts such as simple detection of blood pressure, heart rate 
and blood oxygen saturation of O2, ECG performance, 
blood chemistry testing. 
Telecardiology is also highly relevant in emergency 
services. In fact, by enhancing communication, it can help 
the treatment of patients with chest pain/STEMI quickly  
preserving in most cases the patient's life and drastically 
reduce the acute and chronic complications. The ability to 
shorten the response time is a very significant factor, even 
more than a better resource management.   
In conclusion, we can say that it is definitively proved the 
validity of telecardiology in terms of reducing health 
expenditure for cardiovascular disease, since there is a 
significant reduction of days of hospitalization and cut of 
improper and/or surplus medical acts. It is also evident the 
improvement of patient's life both in clinical and 
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